AAAAAA

   
Results: 1-23 |
Results: 23
Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8(+) T-cell responses in subjects treated early after infection
Authors: Ortiz, GM Hu, J Goldwitz, JA Chandwani, R Larsson, M Bhardwaj, N Bonhoeffer, S Ramratnam, B Zhang, LQ Markowitz, MM Nixon, DF
Citation: Gm. Ortiz et al., Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8(+) T-cell responses in subjects treated early after infection, J VIROLOGY, 76(1), 2002, pp. 411-415
Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells
Authors: Funk, GA Fischer, M Joos, B Opravil, M Gunthard, HF Ledergerber, B Bonhoeffer, S
Citation: Ga. Funk et al., Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells, J ACQ IMM D, 26(5), 2001, pp. 397-404
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection
Authors: Garcia, F Plana, M Ortiz, GM Bonhoeffer, S Soriano, A Vidal, C Cruceta, A Arnedo, M Gil, C Pantaleo, G Pumarola, T Gallart, T Nixon, DF Miro, JM Gatell, JM
Citation: F. Garcia et al., The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection, AIDS, 15(9), 2001, pp. F29-F40
Cooperation and competition in the evolution of ATP-producing pathways (vol 292, pg 504, 2001)
Authors: Pfeiffer, T Schuster, S Bonhoeffer, S
Citation: T. Pfeiffer et al., Cooperation and competition in the evolution of ATP-producing pathways (vol 292, pg 504, 2001), SCIENCE, 293(5534), 2001, pp. 1436-1436
Cooperation and competition in the evolution of ATP-producing pathways
Authors: Pfeiffer, T Schuster, S Bonhoeffer, S
Citation: T. Pfeiffer et al., Cooperation and competition in the evolution of ATP-producing pathways, SCIENCE, 292(5516), 2001, pp. 504-507
Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects
Authors: Ortiz, GM Wellons, M Brancato, J Vo, HTT Zinn, RL Clarkson, DE Van Loon, K Bonhoeffer, S Miralles, GD Montefiori, D Bartlett, JA Nixon, DF
Citation: Gm. Ortiz et al., Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects, P NAS US, 98(23), 2001, pp. 13288-13293
Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: Relationship to viral load in untreated HIV infection
Authors: Betts, MR Ambrozak, DR Douek, DC Bonhoeffer, S Brenchley, JM Casazza, JP Koup, RA Picker, LJ
Citation: Mr. Betts et al., Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: Relationship to viral load in untreated HIV infection, J VIROLOGY, 75(24), 2001, pp. 11983-11991
An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes
Authors: Jin, X Ogg, G Bonhoeffer, S Safrit, J Vesanen, M Bauer, D Chen, D Cao, YZ Demoitie, MA Zhang, LQ Markowitz, M Nixon, D McMichael, A Ho, DD
Citation: X. Jin et al., An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes, MOL MED, 6(9), 2000, pp. 803-809
Risks and benefits of structured antiretroviral drug therapy interruptionsin HIV-1 infection
Authors: Bonhoeffer, S Rembiszewski, M Ortiz, GM Nixon, DF
Citation: S. Bonhoeffer et al., Risks and benefits of structured antiretroviral drug therapy interruptionsin HIV-1 infection, AIDS, 14(15), 2000, pp. 2313-2322
Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia
Authors: Binley, JM Clas, B Gettie, A Vesanen, M Montefiori, DC Sawyer, L Booth, J Lewis, M Marx, PA Bonhoeffer, S Moore, JP
Citation: Jm. Binley et al., Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia, VIROLOGY, 270(1), 2000, pp. 237-249
Production of resistant HIV mutants during antiretroviral therapy
Authors: Ribeiro, RM Bonhoeffer, S
Citation: Rm. Ribeiro et S. Bonhoeffer, Production of resistant HIV mutants during antiretroviral therapy, P NAS US, 97(14), 2000, pp. 7681-7686
High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A0201-positive subjects during multiple viral coinfections
Authors: Jin, X Demoitie, MA Donahoe, SM Ogg, GS Bonhoeffer, S Kakimoto, WM Gillespie, G Moss, PA Dyer, W Kurilla, MG Riddell, SR Downie, J Sullivan, JS McMichael, AJ Workman, C Nixon, DF
Citation: X. Jin et al., High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A0201-positive subjects during multiple viral coinfections, J INFEC DIS, 181(1), 2000, pp. 165-175
Quantification of cell turnover kinetics using 5-bromo-2 '-deoxyuridine
Authors: Bonhoeffer, S Mohri, H Ho, D Perelson, AS
Citation: S. Bonhoeffer et al., Quantification of cell turnover kinetics using 5-bromo-2 '-deoxyuridine, J IMMUNOL, 164(10), 2000, pp. 5049-5054
Evolution of virulence in a heterogeneous host population
Authors: Regoes, RR Nowak, MA Bonhoeffer, S
Citation: Rr. Regoes et al., Evolution of virulence in a heterogeneous host population, EVOLUTION, 54(1), 2000, pp. 64-71
Turning points - A random walk from the cello to the lab
Authors: Bonhoeffer, S
Citation: S. Bonhoeffer, Turning points - A random walk from the cello to the lab, CURR BIOL, 9(1), 1999, pp. R5-R5
A stochastic model for primary HIV infection: optimal timing of therapy
Authors: Ribeiro, RM Bonhoeffer, S
Citation: Rm. Ribeiro et S. Bonhoeffer, A stochastic model for primary HIV infection: optimal timing of therapy, AIDS, 13(3), 1999, pp. 351-357
Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA butnot mRNA following early combination antiretroviral therapy
Authors: Nixon, DF Douek, D Kuebler, PJ Jin, X Vesanen, M Bonhoeffer, S Cao, YZ Koup, RA Ho, DD Markowitz, M
Citation: Df. Nixon et al., Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA butnot mRNA following early combination antiretroviral therapy, IMMUNOL LET, 66(1-3), 1999, pp. 219-228
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis
Authors: Ramratnam, B Bonhoeffer, S Binley, J Hurley, A Zhang, LQ Mittler, JE Markowitz, M Moore, JP Perelson, AS Ho, DD
Citation: B. Ramratnam et al., Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis, LANCET, 354(9192), 1999, pp. 1782-1785
Evolution and disease - Population biology, evolution, and infectious disease: Convergence and synthesis
Authors: Levin, BR Lipsitch, M Bonhoeffer, S
Citation: Br. Levin et al., Evolution and disease - Population biology, evolution, and infectious disease: Convergence and synthesis, SCIENCE, 283(5403), 1999, pp. 806-809
Decay kinetics of human immunodeficiency virus-specific effector cytotoxicT lymphocytes after combination antiretroviral therapy
Authors: Ogg, GS Jin, X Bonhoeffer, S Moss, P Nowak, MA Monard, S Segal, JP Cao, Y Rowland-Jones, SL Hurley, A Markowitz, M Ho, DD McMichael, AJ Nixon, DF
Citation: Gs. Ogg et al., Decay kinetics of human immunodeficiency virus-specific effector cytotoxicT lymphocytes after combination antiretroviral therapy, J VIROLOGY, 73(1), 1999, pp. 797-800
Rapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaques
Authors: Zhang, LQ Dailey, PJ He, T Gettie, A Bonhoeffer, S Perelson, AS Ho, DD
Citation: Lq. Zhang et al., Rapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaques, J VIROLOGY, 73(1), 1999, pp. 855-860
Phenotypic changes in drug susceptibility associated with failure of humanimmunodeficiency virus type 1 (HIV-1) triple combination therapy
Authors: Parkin, NT Lie, YS Hellmann, N Markowitz, M Bonhoeffer, S Ho, DD Petropoulos, CJ
Citation: Nt. Parkin et al., Phenotypic changes in drug susceptibility associated with failure of humanimmunodeficiency virus type 1 (HIV-1) triple combination therapy, J INFEC DIS, 180(3), 1999, pp. 865-870
HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy
Authors: Ortiz, GM Nixon, DF Trkola, A Binley, J Jin, X Bonhoeffer, S Kuebler, PJ Donahoe, SM Demoitie, MA Kakimoto, WM Ketas, T Clas, B Heymann, JJ Zhang, LQ Cao, YZ Hurley, A Moore, JP Ho, DD Markowitz, M
Citation: Gm. Ortiz et al., HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy, J CLIN INV, 104(6), 1999, pp. R13-R18
Risultati: 1-23 |